(PharmaNewsWire.Com, August 09, 2024 ) According to the latest research by InsightAce Analytic, the Global Rapid Microbiology Testing Market is valued at US$ 4.7 Bn in 2023, and it is expected to reach US$ 10.4 Bn by 2031, with a CAGR of 10.7% during the forecast period of 2024-2031. The rapid microbiology...
(PharmaNewsWire.Com, August 09, 2024 ) InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Virtual Urgent Care Market- (By Service (Acute Illness Treatment, Trauma/Injury Treatment, Physical Examinations, Digestive System Issues, Immunizations & Vaccination),...
(PharmaNewsWire.Com, August 09, 2024 ) According to the latest research by InsightAce Analytic, the Global Needle Destroyer Market is valued at US$ 6.2 Bn in 2023, and it is expected to reach US$ 9.1 Bn by 2031, with a CAGR of 5.1% during the forecast period of 2024-2031.A needle destroyer is an...
(PharmaNewsWire.Com, August 09, 2024 ) According to the latest research by InsightAce Analytic, the Global Mental Health Screening Market is valued at US$ 1.04 Bn in 2023, and it is expected to reach US$ 2.62 Bn by 2031, with a CAGR of 12.5% during the forecast period of 2024-2031.The mental health...
(PharmaNewsWire.Com, August 09, 2024 ) According to the latest research by InsightAce Analytic, the Global Hyperpigmentation Disorder Treatment Market is valued at US$ 6.98 Bn in 2023, and it is expected to reach US$ 12.54 Bn by 2031, with a CAGR of 7.8% during the forecast period of 2024-2031.Hyperpigmentation...
(PharmaNewsWire.Com, August 09, 2024 ) According to the latest research by InsightAce Analytic, the Global AI in Oncology Market is valued at US$ 1.2 Bn in 2023, and it is expected to reach US$ 4.5 Bn by 2031, with a CAGR of 18.8% during the forecast period of 2024-2031.Utilizing advanced algorithms...
(PharmaNewsWire.Com, August 09, 2024 ) According to the latest research by InsightAce Analytic, the Global Tongue Retaining Device Market is valued at US$ 528.5 Mn in 2023, and it is expected to reach US$ 1,140.8 Mn by 2031, with a CAGR of 10.3% during the forecast period of 2024-2031.The tongue...
(PharmaNewsWire.Com, August 09, 2024 ) The Targeted Protein Degradation Market is estimated to reach over USD 2.65 Bn by 2031, exhibiting a CAGR of 26.3% during the forecast period. Targeted protein degradation (TPD) seeks to completely remove specific proteins from the cell, rather than merely...
(PharmaNewsWire.Com, August 09, 2024 ) InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Eldercare-Assistive Robots Market – (By Type (Physically Assistive Robots, Socially Assistive Robots), Trends, Industry Competition Analysis, Revenue and Forecast...
(PharmaNewsWire.Com, August 09, 2024 ) The Healthcare Management Service Organization (MSO) Market is estimated to exhibit a CAGR of 10.9% during the forecast period. Healthcare Management Service Organizations (MSOs) are indispensable entities within the healthcare industry, offering a broad spectrum...
(PharmaNewsWire.Com, August 09, 2024 ) InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Celecoxib API Market- (By Type (Standard Grade Celecoxib API, & Micronized Celecoxib API), By Application (Pharmaceutical, & Laboratory)) Trends, Industry Competition...
(PharmaNewsWire.Com, August 09, 2024 ) According to the latest research by InsightAce Analytic, the Global Cardiac Valvulotome Market is valued at US$ 108.8 Mn in 2023, and it is expected to reach US$ 152.0 Mn by 2031, with a CAGR of 4.4% during the forecast period of 2024-2031.The cardiac valvulotome...
(PharmaNewsWire.Com, August 09, 2024 ) According to the latest research by InsightAce Analytic, the Global White (Natural) Hydrogen Market is valued at US$ XX Bn in 2023, and it is expected to reach US$ XX Bn by 2031, with a CAGR of XX% during the forecast period of 2024-2031.White (natural) hydrogen...
(PharmaNewsWire.Com, August 09, 2024 ) According to the latest research by InsightAce Analytic, the Global Vegetable Capsules Market is valued at US$ 1.45 Bn in 2023, and it is expected to reach US$ 3.03 Bn by 2031, with a CAGR of 9.7% during the forecast period of 2024-2031.Get Free Access to Demo...
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: